Evidence map›Paper›PMID 33167400›Full record

ArticleInternational journal of molecular sciences2020

AHR Signaling Interacting with Nutritional Factors Regulating the Expression of Markers in Vascular Inflammation and Atherogenesis.

Carla Dahlem, Sarah Y Kado, Yi He, Keith Bein, Dalei Wu, Thomas Haarmann-Stemmann, Norman Y Kado, Christoph F A Vogel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Mechanisms underlying aryl hydrocarbon receptor-driven divergent macrophage function.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Interleukin-22: a potential therapeutic target in atherosclerosis.Molecular medicine (Cambridge, Mass.) · 2021
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Carla DahlemCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.
Sarah Y KadoCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.
Yi HeCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.
Keith BeinCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.
Dalei WuCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0003-1817-7229
Thomas Haarmann-StemmannLeibniz Research Institute for Environmental Medicine, 40225 Düsseldorf, Germany.
Norman Y KadoDepartment of Environmental Toxicology, University of California, One Shields Avenue, Davis, CA 95616, USA.
Christoph F A VogelCenter for Health and the Environment, University of California, One Shields Avenue, Davis, CA 95616, USA.
University of California, Davis · USLeibniz Institute of Environmental Medicine · DEShandong University · CNUniversity of Konstanz · DE

Funding

UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Irva Hertz-Picciotto · 2015 to 2026
$26.0M
Air pollution, atherosclerosis, and the role of the aryl hydrocarbon receptorR01ES029126 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI VOGEL, CHRISTOPH F A · 2019 to 2023
$1.8M
The protective role of the AhR Repressor in breast cancer developmentR21ES030419 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI VOGEL, CHRISTOPH F A · 2019 to 2020
$432k
NIEHS NIH HHS P30 ES023513NIEHS NIH HHS R01 ES029126NIEHS NIH HHS R01ES029126NIEHS NIH HHS R21 ES030419NIEHS NIH HHS R21ES030419
6 · The paper itself

Abstract

There is strong evidence that exposure to fine particulate matter (PM

Indexed as

AortaAtherosclerosisBasic Helix-Loop-Helix ProteinsBiomarkersCalgranulin BCells, CulturedCholesterolDiet, High-FatEndothelial CellsFructoseGene Expression RegulationGlucoseHumansInflammationMacrophage ActivationMacrophagesAHR protein, humanBasic Helix-Loop-Helix ProteinsBiomarkersCalgranulin BCholesterolFructoseGlucoseNutrientsPalmitic AcidParticulate MatterReceptors, Aryl HydrocarbonS100A9 protein, humanTriglyceridesAHRatherosclerosiscytokinesinflammationmacrophagesobesityPMTCDD

Identifiers

PMID33167400
PMCPMC7663825
OpenAlexW3095597430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.